• Pharma
  • May 14, 2025
  • 399 views
DTAB asks DCGI to take up withdrawal of license for certain FDC antibiotics with SLAs

The Drugs Technical Advisory Board (DTAB) has directed the Central drug regulator to take up the matter related to withdrawal of product license for antibiotic fixed dose combinations (FDCs), which…

  • Pharma
  • April 1, 2021
  • 180 views
Parameters for evaluating FDCs should be changed: IDMA

The Sub-committee of Drugs Technical and Advisory Board (DTAB) is examining the fixed-dose combinations (FDCs) which are considered irrational by Prof Kokate Committee. The committee has asked the concerned applicants to…

NPPA & ICMR together will check usage of Cocktail drugs

NPPA & ICMR together will check usage of Cocktail drugs New Delhi: The Modi government plans to increase monitoring of the usage of cocktail drugs in the country. To that end, the drug…

  • Pharma
  • May 28, 2019
  • 312 views
Drug companies prefer using popular brand names for new products

The central government has ordered state drug controllers not to allow pharma companies to market drug formulations in which the composition has been tweaked while retaining the old brand name.…